Delphi-Panel Analysis of Appropriateness of High-Dose Chemotherapy and Blood Cell or Bone Marrow Autotransplants in Diffuse Large-Cell Lymphoma

References

• Armitage J O. Treatment of non-Hodgkin's lymphoma. N Engl J Med. 1993; 328: 1023–30
   PubMed Web of Science ®Google Scholar
• Goldstone A H, McMillan A K, Copra R. High-dose therapy for the treatment of non-Hodgkin's lymphoma. High-Dose Cancer Therapy, J O Armitage, K H Antman. Williams & Wilkins, Baltimore, MD 1995; 757–9
   Google Scholar
• Passweg J R, Rowlings P A, Armitage J O, . Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. Clinical Transplants, J M Cecka, P I Teras-Kaki, et al. UCLA Tissue Typing Laboratory, Los Angeles, CA 1996; 117–127, 1995
   Google Scholar
• Meehan K R, Pritchard R S, Leichter J W, et al. Autologous bone marrow: estimated transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma of long-term survival from the recent literature. Am J Hematol 1995; 50: 116–23
   PubMed Web of Science ®Google Scholar
• Verdonck L F, Wim L J, Van Putten M SC, et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med. 1995; 332: 1047–51
   Web of Science ®Google Scholar
• Martelli M, Vignetti M, Zinzani L, et al. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized Italian multicenter study. J Clin One. 1996; 14: 534–542
   PubMed Web of Science ®Google Scholar
• Haioun C, Lepage E, Gisselbrecht C, et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87–2. J Clin One. 1997; 15: 1131–1137
   PubMed Web of Science ®Google Scholar
• Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Eng J Med. 1995; 333: 1540–45
   PubMed Web of Science ®Google Scholar
• Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for immediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. J Clin One 1994; 12: 2543–51
   PubMed Web of Science ®Google Scholar
• Gianni A, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N-Engl J Med. 1997; 336: 1290–97
   PubMed Web of Science ®Google Scholar
• Brook R H, Chassin M R, Fink A, et al. A method for the detailed assessment of the appropriateness of medical technologies. Intl J Tech Assess Health Care 1986; 2: 53–63
   PubMedGoogle Scholar
• Brook R H, Chassin M R, Fink A, et al. A method for the detailed assessment of the appropriateness of medical technologies. Intl J Tech Assess Health Care 1986; 2: 53–63
   PubMedGoogle Scholar
• Park R E, Fink A, Brook R H, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J of Publ Health 1986; 76: 766–72
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical use. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Stansfield A, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–293
   Web of Science ®Google Scholar
• International non-Hodgkin's Lymphoma Prognostic Factors Project. a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993; 329: 987–95
   PubMed Web of Science ®Google Scholar
• King S B, 3rd, Lembo N J, Weintraub W S, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emery Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994; 331: 1044–50
   PubMed Web of Science ®Google Scholar
• Hamm C W, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994; 331: 1037–43
   PubMed Web of Science ®Google Scholar
• Roth Well P M. Can overall results of clinical trials be applied to all patients?. Lancet 1995; 345: 1616–9
   PubMed Web of Science ®Google Scholar
• Brook R H. The RAND/UCLA appropriateness method. Clinical practice guideline development: methodology perspectives, K A McCormick, S R Moore, R A Siegel. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Office of the Forum for Quality and Effectiveness in Health Care, Roc-kville, MD 1994; 59–70, Pub. No. 95–0009, 1994; p.59–70.; also available as Brook RH. The RAND/UCLA appropriateness method: Rand/RP-395. Santa Monica, CA: Rand Corporation
   Google Scholar
• Shekelle P G, Chassin M R, Park R E. Evidence for the validity of criteriafor performing carotoid endarterectomy. Int J Tech Assessment in Health Care, (in press)
   PubMedGoogle Scholar
• Merrick N J, Fink A, Park R E, et al. Derivation of clinical indications for carotid endarterectomy by an expert panel. AM J Pub Health 1987; 77: 187–90
   PubMed Web of Science ®Google Scholar
• Shekelle P G, Chassin M R, Park R E. Evidence for the validity of criteria for performing carotoid endarterectomy. N Engl J Med, (in press)
   Google Scholar
• Selby J VB, Fireman B H, Lundstrom R J, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Eng J Med 1996; 335: 1888–96
   PubMed Web of Science ®Google Scholar
• Kravitz R L, Laouri M, Kahan J P, et al. Validity of criteria used for detecting underuse of coronary revascularization. JAMA 1995; 274: 632–8
   PubMed Web of Science ®Google Scholar